France
EUROAPI, founded in 2021, is a leading player in the Health Care and Manufacturing industries, specializing in the production of active pharmaceutical ingredients (APIs). With a broad portfolio of approximately 200 products, the company operates under the slogan "Active Solutions for Health." Their emphasis on research and development, combined with a strong European manufacturing presence, enables them to deliver high-quality API solutions worldwide.
Headquartered in France, EUROAPI manages six manufacturing sites across Europe, ensuring product distribution in over 80 countries. This European industrial platform is recognized for its reliability, quality, and premium client service. The company’s commitment to sustainability and stakeholder satisfaction is central to its operations, as reflected in their vision and mission statements.
The company recently secured a €755.00M post-IPO debt investment from Sanofi as of October 10, 2024. Listed on Euronext Paris, EUROAPI is well-positioned for continued growth and innovation in the pharmaceutical sector.
